title: An oestrogen-producing seminoma responsible for gynaecomastia.
abstract: In feminising testicular tumours, oestrogens can be either secreted by the tumour itself or produced by normal Leydig cells in response to paracrine and/or endocrine stimulation by hCG. Typical hormonal Leydig cell tumour patterns include: plasma oestradiol levels > 300 pmol/l on day 3 following an hCG injection, reduced plasma testosterone, and normal plasma hCG and gonadotrophin levels. Except for elevated plasma oestradiol levels, opposite results are observed in seminomas. We report a case of oestrogen-secreting seminoma mimicking a Leydig cell tumour. A 24-year-old Caucasian patient had complained of gynaecomastia for 6 months before admission. Hormonal pattern was typical of Leydig cell tumour. A 1.4 cm tumour was found in the left testis and confirmed on sonography. Considering the likely diagnosis of Leydig cell tumour, the patient was treated by tumourectomy. Surprisingly, pathological examination revealed a pure seminoma. Perifusion experiments showed that the tumour was able to secrete significant amounts of oestradiol. In addition, hCG induced a two-fold increase in oestradiol production from perifused tumour explants. Immunohistochemistry revealed that the tumour was composed of nests of seminoma cells intermingled with lymphoid infiltrates. Tumour cells also expressed aromatase, the hCG/LH receptor and the Leydig cell marker relaxin-like factor, but were betahCG-negative. These results demonstrate that a pure seminoma of the testis is able to synthesise and secrete oestrogens. They also illustrate that the body of proof favouring the diagnosis of feminising Leydig cell tumour of the testis is not rigorously specific.
authors.affiliation: European Institute for Peptide Research (IFRMP 23), Department of Endocrinology, INSERM U 413, Boisguillaume Hospital, University Hospital of Rouen, 76031 Rouen cedex, France.
authors.forename: C
authors.initials: C
authors.lastname: Duparc
authors.forename: G
authors.initials: G
authors.lastname: Boissiere-Veverka
authors.forename: H
authors.initials: H
authors.lastname: Lefebvre
authors.forename: A
authors.initials: A
authors.lastname: Laquerriere
authors.forename: P
authors.initials: P
authors.lastname: Vuillermet
authors.forename: A
authors.initials: A
authors.lastname: Landreat
authors.forename: R
authors.initials: R
authors.lastname: Ivell
authors.forename: N
authors.initials: N
authors.lastname: DeRoux
authors.forename: J M
authors.initials: JM
authors.lastname: Kuhn
mesh_terms: D000328:Adult; D006063:Chorionic Gonadotropin / Q000097:blood; D004958:Estradiol / Q000097:blood; D004967:Estrogens / Q000096:biosynthesis*; D006177:Gynecomastia / Q000209:etiology; D006728:Hormones / Q000097:blood; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009919:Orchiectomy; D010477:Perfusion; D011863:Radioimmunoassay; D018239:Seminoma / Q000150:complications / Q000378:metabolism*; D013736:Testicular Neoplasms / Q000150:complications / Q000378:metabolism*; D013739:Testosterone / Q000097:blood
chemical_list: D006063:Chorionic Gonadotropin; D004967:Estrogens; D006728:Hormones; D013739:Testosterone; D004958:Estradiol